What Threatens Biosimilars, How Partnerships Protect Them

Bioprocess Online Live’s panel discussion Impact Of The Biosimilars Boom wraps up with a discussion about biosimilar development partnership strategy before reflection on a poll of the audience’s perceived threats to biosimilar strategy. Biosimilars Forum Executive Director Juliana Reed and Celltrion VP of Medical Affairs Hetal Patel, PharmD, MBA offer their closing remarks on continued education, alignment across the healthcare ecosystem, and the shared goal of improving access and affordability through biosimilars.